| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999701 | Urologic Oncology: Seminars and Original Investigations | 2015 | 8 Pages |
Abstract
In a contemporary cohort of men with low-risk prostate cancer, AS allowed avoidance of treatment most of them. Common reasons for change in management were Gleason upgrading and volume progression on prostate rebiopsy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mark A. M.D., M.P.H., Adam S. M.D., M.P.H., John J. M.D., W. Scott M.D., Matthew R. M.D., Ph.D., Jonathan J. Paly, Robert M.D., Chin-Lee M.D., Ph.D., Douglas M. M.D., Glen W. M.D., Michael L. M.D., Anthony I. M.D.,